The principles of the treatment of patients with external ear inflammatory diseases
https://doi.org/10.21518/2079-701X-2018-8-23-28
Abstract
The article reflects the issues of the management of patients with external ear inflammatory diseases. Authors describe the pathogenetic and etiological factors of this pathology development. In the article the principles of conservative treatment and the possibility of using measures that prevent relapses are described, depending on the severity and nature of the pathological process. The paper consists a brief review of clinical studies on the effectiveness of a complex drug with antibacterial, antiinflammatory and antiedematous action based on neomycin, polymyxin B and dexamethasone is reviewed.
About the Authors
V. M. Svistushkin
Sechenov First Moscow State Medical University of the Ministry of Health of Russia
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
H. G. Varosyan
Sechenov First Moscow State Medical University of the Ministry of Health of Russia
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
References
1. Kustov MO. External ear inflammatory diseases. Rossiyskaya Otorinolaringologiya, 2012, 1: 111-118.
2. Turovsky AB, Kryukov AI. Acute inflammation of the external and middle ear. Consilium Medicum, 2000, 8: 323-325.
3. Nikiforova GN, Starostina SV. External otitis: etiology, pathogenesis, features of pharmacotherapy. Method. Guidelines. M., 2014, 20 p.
4. Morozova SV, Karapetyan LS. Complex approach to the management of patients with external otitis media. Farmateka, 2017, 6: 7-11.
5. Kustov MO, Artyushkin SA, Nacharov PV, Verzhbitsky GV, Artyushkina VK, Grebenshchikova LA. The microflora of the external ear canal in patients with bacterial external diffuse otitis. Rossiyskaya Otorinolaringologiya, 2012, 3: 66-70.
6. Sapova KI, Ryazantsev SV. Topical therapy of external otitis of various etiologies. Meditsinskiy Sovet. Shkola Otorinolaringologa, 2017, 16: 92-95.
7. Roland PS, Stroman DW. Microbiology of acute oti-tis externa. Laryngoscope, 2002, 112(7): 1166–1177.
8. Rosenfeld RM, Brown L, Cannon CR, Dolor RJ, Ganiats TG, Hannley M et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg, 2006, 134 (4): 4-23.
9. Stenfors LE, Raisanen S. Quantity of aerobic bacteria in the bony portion of the external auditory canal of children. Int J Pedialr Otorhinolarytigol, 2002, 66(2): 167-73.
10. Borisenko ON, Panchenko TYu. The role of earwax in inflammation of the external ear. Zhurnal Vushnykh, Nosovikh i Gorlovikh Khvorob, 2009, 3: 90-95.
11. Kosyakov SYa, Kurlova AV. Inflammatory diseases of the external ear and methods of their treatment. Vestn. Otorinolar. 2011, 1: 81-84.
12. Palchun VT. Otorhinolaryngology: national guidelines. Edited by Palchun VT. Moscow: GEOTAR-Media, 2008, 11: 565-571
13. Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V. Necrotizing external otitis: a report of 46 cases. Otol Neurotol? 2007, 28(6): 771-773.
14. Rubin Grandis J, Branstetter BF 4th, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet. Infect Dis, 2004, 4: 34-9.
15. Tarasova GD. External otitis media: rationale for treatment and prevention. RMJ, 2017, 5: 346-349.
16. Johnston MN, Flook EP, Mehta D, Mortimore S. Prospective randomised single-blind controlled trial of glacial acetic acid versus glacial acetic acid, neomycin sulphate and dexamethasone spray in otitis externa and infected mastoid cavities. Clin Otolaryngol, 2006, 31(6): 504-507.
17. Shevchik EA, Svistushkin VM. Certain aspects of therapy of external ear inflammatory diseases. RMJ, 2014, 9: 655.
18. Nikitin KA, Arustamyan IG, Boloznevak EV. Local etiotropic treatment for acute external and middle otitis. Meditsinskiy Sovet. Infektsii v Otorinolaringologii? 2013, 7: 22-25.
19. Muller H. Polydexa ear drops: report of a clinical trial. Paris. 1972.
20. Tempera G, Mangiafico A et al. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa. Int J Immunopathol Pharmacol, 2009, 22(2): 299-302.
21. Luchikhin LA, Magomedov MM, Gorbachev VA. Efficacy of ear drops Otofa and Polydexa in the treatment of ear inflammatory diseases. Vestn. Otorinolar. 1999, 4: 130-132.
22. Balyasinskaya G.L. Ear drops Otofa and Polidexa in the treatment of children with acute middle and external otitis. Vestn. Otorinolar. 2003, 3: 53-54.
23. Pesotskaya MV, Miroshnichenko MM, Kuksa EN. Local antibiotic therapy after open-type surgeries for ear in children. Otorinolaringologiya v Belarusi, 2010, 1: 27-31.
24. Poetker DM, Lindstrom DR et al. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea. Arch Otolaryngol Head Neck Surg, 2006, 132(12): 1294-1298.
25. Stockwell M. Gentamicin ear drops and ototoxicity: Update. CMAJ, 2001, 164(1): 93-94.
26. Marais J, Rutka JA. Ototoxicity and topical ear-drops. Clin Otolaryngol Allied Sci, 1998, 23(4): 360-367.
Review
For citations:
Svistushkin VM, Varosyan HG. The principles of the treatment of patients with external ear inflammatory diseases. Meditsinskiy sovet = Medical Council. 2018;(8):23-28. (In Russ.) https://doi.org/10.21518/2079-701X-2018-8-23-28
Views:
713
Email this article 